vimarsana.com

Page 12 - Decision Resources Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chardan Healthcare Acquisition 2 Corp Announces Renovacor s Appointment of Matt Killeen, Ph D , as Chief Scientific Officer

Chardan Healthcare Acquisition 2 Corp Announces Renovacor s Appointment of Matt Killeen, Ph D , as Chief Scientific Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Chardan Healthcare Acquisition 2 Corp Announces Renovacor s Appointment of Matt Killeen, Ph D , as Chief Scientific Officer

Chardan Healthcare Acquisition 2 Corp Announces Renovacor s Appointment of Matt Killeen, Ph D , as Chief Scientific Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Clarivate?Acquires?Bioinfogate, Reinforcing Position as Premier Provider of?End-to-End Research Intelligence Solutions for Life Sciences

(1) Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customers to make more informed decisions? LONDON, Aug. 4, 2021 /PRNewswire/ Clarivate Plc?(NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X?portal.?Financial terms of the transaction were not disclosed.?? The?Bioinfogate?OFF-X?portal is a cutting-edge safety intelligence solution aimed at empowering pharmaceutical organizations to identify toxicology and safety signals, mitigate safety liabilities and de-risk early-stage assets. It is one of the largest?translational safety and toxicity?portals, featuring over 1,200,000 safety alerts corresponding to over 23,000 drugs and biologics and more than 15,000 targets of pharmacological i

Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences

Share this article Share this article Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customers to make more informed decisions  LONDON, Aug. 4, 2021 /PRNewswire/  Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired  Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal. Financial terms of the transaction were not disclosed.    The Bioinfogate OFF-X™ portal is a cutting-edge safety intelligence solution aimed at empowering pharmaceutical organizations to identify toxicology and safety signals, mitigate safety liabilities and de-risk early-stage assets. It is one of the largest translational safety and toxicity portals, featuring over 1,200,000 safety alerts corresponding to over 23,000 d

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.